-
EFSA rejects 7 of first 8 opinions EFSA issues first batch of eight health claims. Only Unilever's plant sterol-based cholesterol-lowering claim gains a thumbs-up. Weight management, blood lipid control and children's development claims all draw negative opinions for varying reasons.
-
EFSA rejects Martek. EFSA confirms industry concerns about the level of scientific backing required to have a claim approved by rejecting a Martek DHA and ARA-infant eye and brain development claim. EFSA said the claim didn't match the science. Martek said it would refine its dossier and resubmit.
-
EFSA approves calcium and vitamin D bone health claims EFSA OKs calcium and vitamin D bone health claims, but turns down omega-3 kids development claims, peptide arterial claims and probiotic kids brain health claims. Valio, which submitted the peptide claim, said it had learnt a lot from the verdict and would resubmit data to win a positive opinion.
-
EFSA approves Benecol cholesterol-lowering claim Benecol joins Unilever in having its cholesterol-lowering claim approved for its stanol-based ingredients.
-
EFSA rejects 5 probiotic claims EFSA turns down five probiotic claims submitted by Polish firm, Institute of Biotechnology, Sera and Vaccines Biomed SA.The dossiers backing the immunity and gut health claims were deemed "weak" by an industry observer.
-
Black tea claim rejected EFSA tells Unilever causality has not been demonstrated between black tea and imporved focus.
-
Cranberry claim canned Ocean Spray's claim linking cranberry and urinary tract infection (UTI) in women fails to impress EFSA's scientists. Ocean Spray commits to resubmitting a stronger dossier.
-
Kids DHA eye healeth claim approved Mead Johnson Nutritionals wins positive verdict for DHA eye health claim. BUT EFSA said the same could not be said for ARA and rejected that part of the claim.
-
Infant gut health claim rejected Food giant Heinz’s Italian subsidiary, Plada Industriale, has infant gut health claim rebuffed for follow-on formulae containing short-chain galacto-oligosaccharides (GOS), acidified milk, nucleotides and beta-palmitate.
-
Danone pulls probiotic claims from process Danone withdraws three article 13.5 claims from process as it awaits further guidance from EFSA.
-
Tomato extract blood circulation claim approved UK company, Provexis, wins positive claim for blood platelet aggregation, wording suggested by EFSA to match the science.
-
EFSA meets with industry to clarify process EFSA calls stakeholders meeting in Brussels to address industry concerns.
-
-
Lycopene-whey heart claim fails UK-based Cambridge Theranostics has its lycopene-based heart and artery health claim turned down. It vows to fight the decision.
